{"mainPropery":{"diseaseId":262,"diseaseName":"Neuropathy ataxia retinitis pigmentosa syndrome","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/262/neuropathy-ataxia-retinitis-pigmentosa-syndrome","synonyms":["NARP syndrome","NARP"],"synonyms-with-source":[{"name":"NARP syndrome"},{"name":"NARP"}],"identifiers":[{"identifierType":"OMIM","identifierId":"551500"},{"identifierType":"ORPHANET","identifierId":"644"},{"identifierType":"UMLS","identifierId":"C1328349"}]},"diseaseCategories":[{"diseaseTypeId":5,"diseaseTypeName":"Congenital and Genetic Diseases","source":"Orphanet"},{"diseaseTypeId":9,"diseaseTypeName":"Eye diseases","source":"Orphanet"},{"diseaseTypeId":14,"diseaseTypeName":"Metabolic disorders"},{"diseaseTypeId":17,"diseaseTypeName":"Nervous System Diseases","source":"Orphanet"},{"diseaseTypeId":33,"diseaseTypeName":"RDCRN"}],"organizations":[{"resourceID":176,"resourceName":"United Mitochondrial Disease Foundation","abbreviation":"","address1":"8085 Saltsburg Road, Suite 201","address2":"","address3":"","address4":"","address5":"","city":"Pittsburgh","state":"PA","zip":"15239 ","country":"United States","phone":"+1-412-793-8077 ","tty":"","tollFree":"1-888-317-8633","fax":"+1-412-793-6477 ","email":"info@umdf.org","url":"https://www.umdf.org","freeText":""},{"resourceID":380,"resourceName":"Retina International","abbreviation":"","address1":"Suite 108, Camden Business Centre ","address2":"12 Camden Row","address3":"","address4":"","address5":"","city":"Dublin 8","state":"","zip":"","country":"Ireland","phone":"+353 1 472 0468","tty":"","tollFree":"","fax":"","email":"avril.daly@retina-International.org","url":"https://www.retina-international.org/","freeText":""}],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.omim.org/551500' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=omim&cmd=Display&dopt=omim_pubmed_calculated&from_uid=551500' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Neuropathy ataxia retinitis pigmentosa syndrome. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":10,"resourceId":13,"resourceName":"MedlinePlus Genetics","descriptionText":"<a href='http://ghr.nlm.nih.gov/condition=neuropathyataxiaandretinitispigmentosa' target='_blank'>Genetics Home Reference (GHR)</a> contains information on Neuropathy ataxia retinitis pigmentosa syndrome. This website is maintained by the National Library of Medicine.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":874,"resourceId":1580,"resourceName":"RDCRN - North American Mitochondrial Disease Consortium (NAMDC)","descriptionText":"The&nbsp;<a href='https://www.rarediseasesnetwork.org/cms/namdc' target='_blank'>North American Mitochondrial Disease Consortium (NAMDC)</a> is a team of doctors, nurses, research coordinators, and research labs throughout the U.S., working together to improve the lives of people with this condition through research.","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":1264,"resourceId":176,"resourceName":"United Mitochondrial Disease Foundation","descriptionText":"You can submit a question to <a href='http://pi.umdf.org/l/346741/2017-11-01/7vxq' target='_blank'>Ask the Mito Doc</a>, a service of the United Mitochondrial Diseases Foundation. Information contained in Ask the Mito Doc<small><sup>SM</sup></small> is for informational and educational purposes only.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1526,"resourceId":2158,"resourceName":"Genetic Testing Registry","descriptionText":"The <a href='http://www.ncbi.nlm.nih.gov/gtr/conditions/C1838914' target='_blank'>Genetic Testing Registry</a> (GTR) provides information about the genetic tests for this condition. The intended audience for the GTR is health care providers and researchers. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.<br />\r\n","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Testing Resources"},{"id":1527,"resourceId":2159,"resourceName":"National Organization for Rare Disorders","descriptionText":"The <a href='http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/1156/viewAbstract' target='_blank'>National Organization for Rare Disorders</a> (NORD) has a report for patients and families about this condition. NORD is a patient advocacy organization for individuals with rare diseases and the organizations that serve them.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=644' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1537,"resourceId":2168,"resourceName":"GeneReviews","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=narp' target='_blank'>GeneReviews</a> provides current, expert-authored, peer-reviewed, full-text articles describing the application of genetic testing to the diagnosis, management, and genetic counseling of patients with specific inherited conditions.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1539,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/ResearchTrials_ResearchProjects_Simple.php?lng=EN&LnkId=182&Typ=Pat' target='_blank'>Orphanet</a> lists European clinical trials, research studies, and patient registries enrolling people with this condition.&nbsp;","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":1541,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/ClinicalLabs_Search_Simple.php?lng=EN&LnkId=182&Typ=Pat' target='_blank'>Orphanet</a> lists international laboratories offering diagnostic testing for this condition.","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Testing Resources"},{"id":1892,"resourceId":44,"resourceName":"National Ataxia Foundation","descriptionText":"The <a href='https://ataxia.org/neurologists-and-specialty-clinics/#AtaxiaClinics' target='_blank'>National Ataxia Foundation</a>, a nonprofit organization dedicated to improving the lives of persons affected by ataxia, provides lists of neurologists, ataxia clinics, and movement disorder clinics.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/OMIM:551500' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":2869,"questionText":"What is neuropathy ataxia&nbsp;retinitis pigmentosa (NARP) syndrome?","answerText":"<strong>Neuropathy ataxia&nbsp;retinitis pigmentosa (NARP) syndrome</strong>&nbsp;is characterized by a variety of signs and symptoms that mainly affect the nervous system. Beginning in childhood or early adulthood, most people with NARP experience numbness, tingling, or pain in the arms and legs (sensory neuropathy); muscle weakness; and problems with balance and coordination (<a href=\"http://www.ataxia.org/learn/ataxia-diagnosis.aspx#what-is-ataxia\" target=\"_blank\" tabindex=\"-1\">ataxia</a>). Affected individuals may also have vision loss caused by&nbsp;a condition called <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/001029.htm\" target=\"_blank\" tabindex=\"-1\">retinitis pigmentosa</a>. Other features of NARP include learning disabilities, <a href=\"http://www.parentcenterhub.org/repository/ei-overview/#delay\" target=\"_blank\" tabindex=\"-1\">developmental delay</a>, <a href=\"http://www.nlm.nih.gov/medlineplus/seizures.html\" target=\"_blank\" tabindex=\"-1\">seizures</a>, <a href=\"http://www.nlm.nih.gov/medlineplus/dementia.html\" target=\"_blank\" tabindex=\"-1\">dementia</a>, hearing loss, and <a href=\"http://www.nlm.nih.gov/medlineplus/ency/imagepages/18052.htm\" target=\"_blank\" tabindex=\"-1\">cardiac conduction defects</a>. Mutations in the <a class=\"link-dapple\" title=\"M T - A T P 6\" href=\"http://ghr.nlm.nih.gov/gene=mtatp6\" target=\"_blank\" tabindex=\"-1\"><em>MT-ATP6</em></a> gene cause NARP syndrome.&nbsp;This gene is located  within <a href=\"http://ghr.nlm.nih.gov/chromosome=MT\" target=\"_blank\" tabindex=\"-1\">mitochondrial DNA</a>&nbsp;(mtDNA).[1879] Most individuals with NARP have a specific <em>MT-ATP6</em> mutation in 70 percent to 90 percent of their mitochondria.[1880] NARP syndrome is inherited from the mother (maternal inheritance) because only females pass mitochondrial DNA&nbsp;to their children.[1879]","dateModified":"2016-01-27T00:00:00"},"basicQuestions":[],"references":[],"relatedDiseases":[],"gardCases":[{"caseId":25398,"abbreviatedInquiry":"How is neuropathy ataxia retinitis pigmentosa&nbsp;(NARP) related to maternally inherited Leigh syndrome (MILS)?","caseQuestions":[{"questionId":2870,"questionText":"How is neuropathy ataxia retinitis pigmentosa&nbsp;(NARP) related to mitochondrial DNA-associated Leigh syndrome?","answerText":"NARP and mitochondrial DNA-associated Leigh syndrome are part of a continuum of progressive neurodegenerative disorders.[1881]<br />\r\n<br />\r\nThese conditions affect <a href=\"http://www.mitoaction.org/mito-faq#whatare\" target=\"_blank\">mitochondria</a>, which are structures within cells that convert the energy from food into a form that cells can use. NARP and MILS can be caused by mutations in the <a href=\"http://ghr.nlm.nih.gov/gene=mtatp6\" target=\"_blank\" tabindex=\"-1\"><em>MT-ATP6</em> gene</a>, which is contained within <a href=\"http://ghr.nlm.nih.gov/chromosome=MT\" target=\"_blank\" tabindex=\"-1\">mitochondrial DNA</a>.&nbsp;Although most <a href=\"http://ghr.nlm.nih.gov/handbook/basics/dna\" target=\"_blank\" tabindex=\"-1\">DNA</a> is packaged in <a href=\"https://www.nlm.nih.gov/medlineplus/ency/article/002327.htm\" target=\"_blank\" tabindex=\"-1\">chromosomes</a> within the <a href=\"http://ghr.nlm.nih.gov/handbook/illustrations/cellparts?show=cellnucleus\" target=\"_blank\" tabindex=\"-1\">nucleus</a>, mitochondria also have a small amount of their own DNA. The most common genetic change in the&nbsp;<em>MT-ATP6</em> gene&nbsp;replaces the DNA building block thymine with guanosine at position 8993 (written as T8993G).[1880]<br />\r\n<br />\r\nMost of the body's cells contain thousands of mitochondria, each with one or more copies of <a href=\"http://ghr.nlm.nih.gov/handbook/basics/mtdna\" target=\"_blank\" tabindex=\"-1\">mitochondrial DNA</a>. The severity of some mitochondrial disorders is associated with the percentage of mitochondria in each cell that has a particular genetic mutation. Most individuals with NARP have the&nbsp;T8993G mutation in&nbsp;70 to 90 percent of their mitochondria. When this mutation is present in a higher percentage of a person's mitochondria&mdash;greater than 90&nbsp;percent&mdash;it causes&nbsp;the more severe features of mitochondrial DNA-associated Leigh syndrome.&nbsp;Because these two conditions can result from the same genetic changes and can occur in different members of a single family, researchers believe that they represent a spectrum of overlapping features instead of two distinct syndromes.[1879]","dateModified":"2016-01-27T00:00:00","resourceClassificationName":"Inheritance","references":[{"referenceId":1879,"authors":"","articleTitle":"Neuropathy, ataxia, and retinitis pigmentosa","bookWebsiteJournalTitle":"Genetics Home Reference","date":"November 2006","volume":"","pages":"","url":"http://ghr.nlm.nih.gov/condition/neuropathy-ataxia-and-retinitis-pigmentosa","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":1880,"authors":"","articleTitle":"MT-ATP6","bookWebsiteJournalTitle":"Genetics Home Reference","date":"October 2011","volume":"","pages":"","url":"http://ghr.nlm.nih.gov/gene/MT-ATP6","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":1881,"authors":"Thornburn DR, Rahman SR","articleTitle":"Mitochondrial DNA-Associated Leigh Syndrome and NARP","bookWebsiteJournalTitle":"GeneReviews","date":"April 17, 2014","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1173/","authors2":"","placeOfPublication":"","publisher":""}]}]}],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":8746,"phenoTypeName":"Abnormal basal ganglia MRI signal intensity","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":14677,"phenoTypeName":"Abnormal visual field test","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13598,"phenoTypeName":"Babinski sign","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":10089,"phenoTypeName":"Blindness","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13743,"phenoTypeName":"Cerebral cortical atrophy","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":3035,"phenoTypeName":"Constriction of peripheral visual field","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13078,"phenoTypeName":"Corticospinal tract atrophy","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":6020,"phenoTypeName":"Dementia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":8723,"phenoTypeName":"Global developmental delay","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":11409,"phenoTypeName":"Headache","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":11303,"phenoTypeName":"Hearing impairment","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":5130,"phenoTypeName":"Intellectual disability, severe","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":10038,"phenoTypeName":"Irritability","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":5588,"phenoTypeName":"Muscle spasm","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":5305,"phenoTypeName":"Myoclonic spasms","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":10109,"phenoTypeName":"Nystagmus","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":5651,"phenoTypeName":"Optic disc pallor","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13630,"phenoTypeName":"Progressive gait ataxia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":5281,"phenoTypeName":"Proximal muscle weakness","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":3038,"phenoTypeName":"Retinal arteriolar tortuosity","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":8479,"phenoTypeName":"Retinal pigment epithelial mottling","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":5620,"phenoTypeName":"Rod-cone dystrophy","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":8719,"phenoTypeName":"Seizure","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":14147,"phenoTypeName":"Sensory neuropathy","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":3605,"phenoTypeName":"Short stature","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13742,"phenoTypeName":"Ventriculomegaly","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":8720,"phenoTypeName":"Ataxia","percentRanges":"-"},{"phenoTypeId":8122,"phenoTypeName":"Mitochondrial inheritance","percentRanges":"-"},{"phenoTypeId":5303,"phenoTypeName":"Mitochondrial myopathy","percentRanges":"-"},{"phenoTypeId":14500,"phenoTypeName":"Myopathy","percentRanges":"-"},{"phenoTypeId":10492,"phenoTypeName":"Retinopathy","percentRanges":"-"}],"medicalProducts":[],"EncodedName":"Neuropathy_ataxia_retinitis_pigmentosa_syndrome"}